HFMREF

Clinical trials for HFMREF explained in plain language.

Never miss a new study

Get alerted when new HFMREF trials appear

Sign up with your email to follow new studies for HFMREF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug duo aims to ease strain on failing hearts and lungs

Disease control Not yet recruiting

This study is testing if adding the drug macitentan to a standard heart failure drug (dapagliflozin) works better for patients who have a specific type of heart failure combined with high blood pressure in the lungs. About 64 participants will be randomly assigned to take either …

Matched conditions: HFMREF

Phase: PHASE4 • Sponsor: Gachon University Gil Medical Center • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

HFMREF

Get alerted when new HFMREF trials appear

New drug duo aims to ease strain on failing hearts and lungs